Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma.
J Clin Oncol
; 39(20): 2257-2265, 2021 07 10.
Article
in En
| MEDLINE
| ID: mdl-33909449
Full text:
1
Database:
MEDLINE
Main subject:
Hodgkin Disease
/
Antineoplastic Combined Chemotherapy Protocols
/
Chemoradiotherapy
/
Antineoplastic Agents, Immunological
/
Brentuximab Vedotin
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
America do norte
Language:
En
Journal:
J Clin Oncol
Year:
2021
Type:
Article